Translational therapeutics of dipyridamole. - Wikidata - awgldk - TriplyDB

Translational therapeutics of dipyridamole.

Translational therapeutics of dipyridamole.

http://www.wikidata.org/entity/Q37041703

about

Anti-platelet therapy: phosphodiesterase inhibitors.Proton-coupled electron-transfer mechanism for the radical scavenging activity of cardiovascular drug dipyridamole PDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER.Ischemic stroke followed by acute thrombocytopenia: a double iatrogenic whammy.Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication Therapeutic modulation of cerebral microhemorrhage in a mouse model of cerebral amyloid angiopathy.Mixed cerebrovascular disease and the future of stroke prevention.Monocyte chemotactic protein-1 as a potential biomarker for early anti-thrombotic therapy after ischemic stroke.High-throughput screening for modulators of ACVR1 transcription: discovery of potential therapeutics for fibrodysplasia ossificans progressiva.Selective amplification of glucocorticoid anti-inflammatory activity through synergistic multi-target action of a combination drug P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic window Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis.Brain regulation of thrombosis and hemostasis: from theory to practice.The intelligent use of systemic glucocorticoids in rheumatoid arthritis.Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration.Exercise versus vasodilator stress limb perfusion imaging for the assessment of peripheral artery disease.Amelioration of inflammation and cytotoxicity by dipyridamole in brain endothelial cells Biphasic increase of gap junction coupling induced by dipyridamole in the rat aortic A-10 vascular smooth muscle cell line.Human pyrimidine nucleotide biosynthesis as a target for antiviral chemotherapy.Recombinant amphiphilic protein micelles for drug delivery.Dipyridamole potentiated the trypanocidal effect of nifurtimox and improved the cardiac function in NMRI mice with acute chagasic myocarditis.Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties.Presumed hydrogen sulfide-mediated neurotoxicity after streptococcus anginosus group meningitis.Dipyridamole-induced headache and lower recurrence risk in secondary prevention of ischaemic stroke: a post hoc analysis.Longitudinal assessment of thrombin generation potential in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial.Dipyridamole potentiated the trypanocidal effect of nifurtimox and improved the cardiac function in NMRI mice with acute chagasic myocarditis.Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome.Genetic Understanding of Stroke Treatment: Potential Role for Phosphodiesterase Inhibitors.Dipyridamole intervention of breast cell carcinogenesis.

P2860

Q27687228-D5AA5496-6FF1-4DB0-B529-4756161A5163 Q28480596-753E47F5-DF90-46F7-8FAB-AD761B1C16E9 Q30987183-951983E7-E2DD-4C6A-A06E-3E13900E39BA Q33385757-AF83C873-801C-43A5-B03A-CA54B8FAD71A Q33566587-A5E98894-5B6D-4EF1-A920-79A8D4B3A8E0 Q35565914-B36342DA-DB49-4D2C-9E99-8A5EA27CA55B Q36025087-61FE6E36-FBFB-4E00-ABD8-7793BD14C65E Q36197280-98DFC464-4080-40EE-8A95-F1C095B7CA73 Q37036154-0D673BBE-1B92-4053-8F02-74014E5CCE17 Q37207076-4EA54B66-6608-4D26-B4D3-757938C32A38 Q37494937-D22B448A-690D-4C12-B75C-F6ABA35AD6C6 Q37971308-8C16C007-B4FE-4510-A226-B260545F4B8D Q38042445-FBAF8799-CB68-48DC-B347-27BB9892005B Q38148437-8CF6B675-D3DB-4754-9E50-EADCF829F5BB Q38168952-F960A88A-18A2-4E5E-AB01-60836289C3DB Q38676937-6BC76815-757E-4910-AF26-D862473D1691 Q38700884-D1F39048-4423-49B8-99C3-AC7CB3815FE9 Q39066002-CACDB227-3D8A-439C-9702-8CC1FA790CB8 Q39181980-B38A175A-AB10-43BD-878D-C0792B6BD69E Q39273755-C19FED9C-5266-4DC4-A424-2A4120372FF7 Q39468785-19BA6A1E-A9DC-4485-802E-FC47F93CBEE1 Q40049271-1B87ADE0-8593-4184-9892-639A829D4F45 Q41718404-9BA4EEFD-2DC5-4BE2-A8ED-DA5352AA282A Q42166117-DA4DEEDA-6E16-4288-8F55-24BD561B6A36 Q44263191-B9980683-B8EF-4F89-AFC9-F6739AC2E99A Q44857549-A7E33F5B-5BC3-4E34-A802-021D684600A5 Q45861292-2B93654B-1EAF-492C-B738-2185E51665E7 Q47105513-7A2B1B62-5EEA-4729-B565-8C075AAD09C1 Q47642330-D0DF9E7F-96C3-4DA1-9193-4C28C6C2F695 Q48093627-2A9BD6B8-9F8C-41A1-BD40-122C2ADEC7C4 Q54476969-25F1415F-068A-4033-A5C7-761CDE8BB69B

P2860

Translational therapeutics of dipyridamole.

http://www.wikidata.org/entity/Q37041703

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Translational therapeutics of dipyridamole.

@en

Translational therapeutics of dipyridamole.

@nl

type

label

Translational therapeutics of dipyridamole.

@en

Translational therapeutics of dipyridamole.

@nl

prefLabel

Translational therapeutics of dipyridamole.

@en

Translational therapeutics of dipyridamole.

@nl

P1433

Q37041703-69B3E204-821F-40B9-A43A-3FE7AC5080A0

P1476

Q37041703-01D3A39D-70A1-46EB-A9AD-305C1F22CC8E

P2093

Q37041703-42BD6211-F104-45E4-B0CE-F87B4F76F6FD

Q37041703-AB0C1E61-7F9E-437C-A032-7A0B2B5D81FD

P2860

Q37041703-079DEB1D-6926-46BC-9302-C959BEE47EE8

Q37041703-0975796E-0112-42E6-A7A9-6219A9B71E97

Q37041703-1F8C5A93-92A1-476A-B6AC-DB36ADE4D447

Q37041703-23376175-8AEB-4CA8-BD3D-56A7F167570B

Q37041703-2B3E3F48-C670-43C7-9DD7-0CAD74C727A9

Q37041703-31459AA3-1F03-4917-BD2B-E47CFAAC43B7

Q37041703-363D9ADB-4469-4912-A038-D7CF564E0447

Q37041703-37DCF219-0CA7-409C-BDB1-9B9E32E73B8E

Q37041703-4CFD09B7-1AA3-48CA-B1D8-2D9C1DC12774

Q37041703-4D3034D7-452D-4CB9-84DC-8B168A291EF6

P304

Q37041703-03B1967E-630B-4E4E-AB0D-4646D7CD0476

P31

Q37041703-63F4E93D-B4BD-47A9-A530-EDB1AA9EA845

P356

Q37041703-F984D93E-DABF-4896-81E4-3809306411D7

P407

Q37041703-47E947F1-4BB7-4FB6-AA10-3DA5DB13216B

P433

Q37041703-0C2EBA7C-434B-433E-8333-BC57A23F8BC8

P478

Q37041703-7F113EEC-44C4-4D77-93EF-373BB7E5BFC1

P577

Q37041703-B3CA4526-0A53-4981-B7AC-01A5C96C4C6B

P5875

Q37041703-DB60ED79-4052-4A13-987A-A6183946659C

P698

Q37041703-4B59E696-02B3-4FB3-A27D-55DB04281E42

P932

Q37041703-AD6D6BD9-092D-44EC-B568-751E7A287110

P356

ATVBAHA.107.160226

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Translational therapeutics of dipyridamole.

@en

P2093

Hyung-Hwan Kim

http://www.w3.org/2001/XMLSchema#string

James K Liao

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

Effect of chronic sustained-release dipyridamole on myocardial blood flow and left ventricular function in patients with ischemic cardiomyopathy

Dipyridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

P304

s39-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.107.160226

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5676451

http://www.w3.org/2001/XMLSchema#string

P698

18174451

http://www.w3.org/2001/XMLSchema#string

P932

2615560

http://www.w3.org/2001/XMLSchema#string